|
Market Closed -
Nasdaq
04:00:00 01/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 198.52 USD | -0.25% |
|
-3.35% | +8.69% |
| 08-31 | Axsome Therapeutics Initiates SUMMIT Phase 3 Trial Of AXS-05 In Smoking Cessation | CI |
| 08-31 | Axsome Therapeutics Starts Phase 3 Trial of AXS-05 for Smoking Cessation | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXSOME THERAPEUTICS, INC. | Biopharmaceuticals | -0.25% | -3.35% | +8.69% | +60.78% | +673.05% | 10.4B |  |  | |
- Stock Market
- Stocks
- AXSM Stock
- Charts Axsome Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
